| Campbell RK
Type 2 diabetes: Where we are today: An overview of disease burden, current treatments, and treatment strategies. [JOURNAL ARTICLE]
J Am Pharm Assoc (2003) 2009 September-October 1; 49(5):S3-S9.
Abstract | Full Citation |
| White J
Efficacy and safety of incretinbased therapies: Clinical trial data. [JOURNAL ARTICLE]
J Am Pharm Assoc (2003) 2009 September-October 1.:S30-S40.
Abstract | Full Citation | Find Related Articles |
| Campbell RK, Neumiller JJ, White J, et al.
Type 2 diabetes: Epidemiology and treatment, pathophysiology, new therapeutics, and the evolving role of the pharmacist. [JOURNAL ARTICLE]
J Am Pharm Assoc (2003) 2009 September-October 1.:S2.
Full Citation | Find Related Articles |
| Neumiller JJ
Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. [JOURNAL ARTICLE]
J Am Pharm Assoc (2003) 2009 September-October 1.:S16-S29.
Abstract | Full Citation | Find Related Articles |
| Kulasa KM, Henry RR
Pharmacotherapy of hyperglycemia. [JOURNAL ARTICLE]
Expert Opin Pharmacother 2009 Sep 10.
Abstract | Full Citation |
| Horie Y, Hayashi N, Dugi K, et al.
Design, statistical analysis and sample size calculation of a phase IIb/III study of linagliptin versus voglibose and placebo. [JOURNAL ARTICLE]
Trials 2009 Sep 5; 10(1):82.
Abstract | Full Citation | Find Related Articles |
| Traynor K
FDA approves saxagliptin for type 2 diabetes. [News]
Am J Health Syst Pharm 2009 Sep 1; 66(17):1513.
Full Citation | Publisher Full Text | Find Related Articles |
| Sitagliptin + metformin: new combination. Do not use this combination. [Journal Article]
Prescrire Int 2009 Jun; 18(101):115.
Abstract | Full Citation |
| Kendall DM, Cuddihy RM, Bergenstal RM
Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use. [Journal Article]
Eur J Intern Med 2009 Jul.:S329-39.
Abstract | Full Citation | Find Related Articles |
| Bloomfield DM, Krishna R, Hreniuk D, et al.
A Thorough QTc Study to Assess the Effect of Sitagliptin, a DPP4 Inhibitor, on Ventricular Repolarization in Healthy Subjects. [Journal Article]
J Clin Pharmacol 2009 Aug; 49(8):937-46.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
